Introduction Effective use of pre‐exposure prophylaxis (PrEP) has been low among
adolescent girls and young women (AGYW) in sub‐Saharan Africa. The MTN‐034/REACH …

Introduction Pre-exposure prophylaxis (PrEP) is a highly effective HIV prevention strategy
and is recommended for populations at risk of HIV, including adolescent girls and young …

Introduction Oral pre‐exposure prophylaxis (PrEP) has the potential to reduce HIV
acquisition among adolescent girls and young women (AGYW) in sub‐Saharan Africa, a …

Background Pre-exposure prophylaxis (PrEP) is highly effective and an important prevention
tool for African adolescent girls and young women (AGYW), but adherence and persistence …

Background Adolescent girls and young women in southern and eastern Africa have
adherence challenges with daily oral HIV pre-exposure prophylaxis (PrEP). High adherence …

Introduction Adolescent girls and young women (AGYW) in sub-Saharan Africa are
disproportionately affected by the HIV epidemic and face an array of challenges using …

Background HIV incidence among South African adolescent girls and young women
(AGYW) remains high, but could be reduced by highly effective pre-exposure prophylaxis …

Introduction Adolescent girls and young women (AGYW) in Africa have high HIV incidence
despite scale‐up of HIV testing and HIV treatment. Placebo‐controlled trials of tenofovir …

Despite demonstrated efficacy for HIV prevention, substantial challenges remain for the
successful rollout of oral pre-exposure prophylaxis (PrEP), especially among adolescent …

Adolescent girls and young women (AGYW) in sub-Saharan Africa represent a key
population at risk for acquiring HIV infection. Oral antiretroviral pre-exposure prophylaxis, or …